サンプル依頼リスト カート
  • English
デフォルト表紙
市場調査レポート
商品コード
1339855

世界の単発性疾患検査市場：考察と予測 (2029年まで)

Global Monogenic Disease Testing Market Insights, Forecast to 2029
出版日: | 発行: QYResearch | ページ情報: 英文 91 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.76円
世界の単発性疾患検査市場：考察と予測 (2029年まで)
出版日: 2023年08月29日
発行: QYResearch
ページ情報: 英文 91 Pages
納期: 2～3営業日
ご注意事項 :
本レポートは最新情報反映のため適宜更新し、内容構成変更を行う場合があります。ご検討の際はお問い合わせください。
  • 全表示
  • 概要
  • 図表
  • 目次
概要

当レポートは、単発性疾患検査 (Monogenic Disease Testing) 市場について調査しており、市場規模や動向・需要の予測、成長要因および課題の分析、タイプ・用途・企業・地域別の内訳、競合情勢、主要企業のプロファイルなどの情報を提供しています。

目次

第1章 レポート概要

  • 調査範囲
  • 市場分析：タイプ別
    • 世界の単発性疾患検査の市場規模成長率：タイプ別, 2018 VS 2022 VS 2029
    • Carrier Testing
    • Diagnostic Testing
    • New-Born Screening
    • Predictive and Pre-Symptomatic Testing
    • Prenatal Testing
  • 市場：用途別
    • 世界の単発性疾患検査の市場規模成長率：用途別, 2018 VS 2022 VS 2029
    • Hospitals
    • Clinics
    • Others
  • 前提条件と制限
  • 調査目的
  • 対象期間

第2章 世界の市場成長トレンド

  • 世界の単発性疾患検査の市場展望 (2018-2029)
  • 世界の単発性疾患検査の市場成長トレンド：地域別
    • 単発性疾患検査 市場規模：地域別: 2018 VS 2022 VS 2029
    • 単発性疾患検査の市場規模実績：地域別 (2018-2023)
    • 単発性疾患検査の市場規模予測：地域別 (2024-2029)
  • 単発性疾患検査 市場動向
    • 単発性疾患検査 業界動向
    • 単発性疾患検査 市場の促進要因
    • 単発性疾患検査 市場の課題
    • 単発性疾患検査 市場の抑制要因

第3章 競合情勢：主要企業別

  • 世界規模の売上高 単発性疾患検査 ：競合別
    • 世界の単発性疾患検査の収益：企業別 (2018-2023)
    • 世界の単発性疾患検査の収益シェア：企業別 (2018-2023)
  • 世界の単発性疾患検査の市場シェア：企業タイプ別 (Tier 1, Tier 2, and Tier 3)
  • 世界の主要企業 単発性疾患検査, 売上高ランキング, 2021 VS 2022 VS 2023
  • 世界の単発性疾患検査 市場集中度
    • 世界の単発性疾患検査 市場集中度 (CR5 and HHI)
    • 世界の上位10・上位5企業： 単発性疾患検査の収益 2022
  • 世界の主要企業 単発性疾患検査 本社 および提供地域
  • 世界の主要企業 単発性疾患検査, 製品およびアプリケーション
  • 世界の主要企業 単発性疾患検査, 業界参入時期
  • M&A, 拡張計画

第4章 単発性疾患検査 内訳データ：タイプ別

  • 世界の単発性疾患検査の市場規模実績：タイプ別 (2018-2023)
  • 世界の単発性疾患検査の市場規模予測：タイプ別 (2024-2029)

第5章 単発性疾患検査 内訳データ：用途別

  • 世界の単発性疾患検査の市場規模実績：用途別 (2018-2023)
  • 世界の単発性疾患検査の市場規模予測：用途別 (2024-2029)

第6章 北米

  • 北米の単発性疾患検査 市場規模 (2018-2029)
  • 北米の単発性疾患検査 市場規模：タイプ別
    • 北米の単発性疾患検査 市場規模：タイプ別 (2018-2023)
    • 北米の単発性疾患検査 市場規模：タイプ別 (2024-2029)
    • 北米の単発性疾患検査の市場シェア：タイプ別 (2018-2029)
  • 北米の単発性疾患検査 市場規模：用途別
    • 北米の単発性疾患検査 市場規模：用途別 (2018-2023)
    • 北米の単発性疾患検査 市場規模：用途別 (2024-2029)
    • 北米の単発性疾患検査の市場シェア：用途別 (2018-2029)
  • 北米の単発性疾患検査 市場規模：国別
    • 北米の単発性疾患検査 市場規模：国別: 2018 VS 2022 VS 2029
    • 北米の単発性疾患検査 市場規模：国別 (2018-2023)
    • 北米の単発性疾患検査 市場規模：国別 (2024-2029)
    • 米国
    • カナダ

第7章 欧州

  • 欧州の単発性疾患検査 市場規模 (2018-2029)
  • 欧州の単発性疾患検査 市場規模：タイプ別
    • 欧州の単発性疾患検査 市場規模：タイプ別 (2018-2023)
    • 欧州の単発性疾患検査 市場規模：タイプ別 (2024-2029)
    • 欧州の単発性疾患検査の市場シェア：タイプ別 (2018-2029)
  • 欧州の単発性疾患検査 市場規模：用途別
    • 欧州の単発性疾患検査 市場規模：用途別 (2018-2023)
    • 欧州の単発性疾患検査 市場規模：用途別 (2024-2029)
    • 欧州の単発性疾患検査の市場シェア：用途別 (2018-2029)
  • 欧州の単発性疾患検査 市場規模：国別
    • 欧州の単発性疾患検査 市場規模：国別: 2018 VS 2022 VS 2029
    • 欧州の単発性疾患検査 市場規模：国別 (2018-2023)
    • 欧州の単発性疾患検査 市場規模：国別 (2024-2029)
    • ドイツ
    • フランス
    • 英国
    • イタリア
    • ロシア
    • 北欧

第8章 中国

  • 中国の単発性疾患検査 市場規模 (2018-2029)
  • 中国の単発性疾患検査 市場規模：タイプ別
    • 中国の単発性疾患検査 市場規模：タイプ別 (2018-2023)
    • 中国の単発性疾患検査 市場規模：タイプ別 (2024-2029)
    • 中国の単発性疾患検査の市場シェア：タイプ別 (2018-2029)
  • 中国の単発性疾患検査 市場規模：用途別
    • 中国の単発性疾患検査 市場規模：用途別 (2018-2023)
    • 中国の単発性疾患検査 市場規模：用途別 (2024-2029)
    • 中国の単発性疾患検査の市場シェア：用途別 (2018-2029)

第9章 アジア（中国を除く）

  • アジア地域 単発性疾患検査 市場規模 (2018-2029)
  • アジア地域 単発性疾患検査 市場規模：タイプ別
    • アジア地域 単発性疾患検査 市場規模：タイプ別 (2018-2023)
    • アジア地域 単発性疾患検査 市場規模：タイプ別 (2024-2029)
    • アジア地域 単発性疾患検査の市場シェア：タイプ別 (2018-2029)
  • アジア地域 単発性疾患検査 市場規模：用途別
    • アジア地域 単発性疾患検査 市場規模：用途別 (2018-2023)
    • アジア地域 単発性疾患検査 市場規模：用途別 (2024-2029)
    • アジア地域 単発性疾患検査の市場シェア：用途別 (2018-2029)
  • アジア地域 単発性疾患検査 市場規模：地域別
    • アジア地域 単発性疾患検査 市場規模：地域別: 2018 VS 2022 VS 2029
    • アジア地域 単発性疾患検査 市場規模：地域別 (2018-2023)
    • アジア地域 単発性疾患検査 市場規模：地域別 (2024-2029)
    • 日本
    • 韓国
    • 台湾
    • 東南アジア
    • インド
    • オーストラリア

第10章 中近東・アフリカ・中南米

  • 中近東・アフリカ・中南米 単発性疾患検査 市場規模 (2018-2029)
  • 中近東・アフリカ・中南米 単発性疾患検査 市場規模：タイプ別
    • 中近東・アフリカ・中南米 単発性疾患検査 市場規模：タイプ別 (2018-2023)
    • 中近東・アフリカ・中南米 単発性疾患検査 市場規模：タイプ別 (2024-2029)
    • 中近東・アフリカ・中南米 単発性疾患検査の市場シェア：タイプ別 (2018-2029)
  • 中近東・アフリカ・中南米 単発性疾患検査 市場規模：用途別
    • 中近東・アフリカ・中南米 単発性疾患検査 市場規模：用途別 (2018-2023)
    • 中近東・アフリカ・中南米 単発性疾患検査 市場規模：用途別 (2024-2029)
    • 中近東・アフリカ・中南米 単発性疾患検査の市場シェア：用途別 (2018-2029)
  • 中近東・アフリカ・中南米 単発性疾患検査 市場規模：国別
    • 中近東・アフリカ・中南米 単発性疾患検査 市場規模：国別: 2018 VS 2022 VS 2029
    • 中近東・アフリカ・中南米 単発性疾患検査 市場規模：国別 (2018-2023)
    • 中近東・アフリカ・中南米 単発性疾患検査 市場規模：国別 (2024-2029)
    • ブラジル
    • メキシコ
    • トルコ
    • サウジアラビア
    • イスラエル
    • 湾岸協力理事会諸国

第11章 主要企業のプロファイル

  • Celera Support Services
  • Abbott
  • ELITech Group
  • Auto Genomics
  • PerkinElmer
  • Bio-Rad Laboratories

第12章 アナリストによる分析/結論

第13章 付録

図表

List of Tables

  • Table 1. Global Monogenic Disease Testing Market Size Growth Rate by Type (US$ Million), 2018 VS 2022 VS 2029
  • Table 2. Key Players of Carrier Testing
  • Table 3. Key Players of Diagnostic Testing
  • Table 4. Key Players of New-Born Screening
  • Table 5. Key Players of Predictive and Pre-Symptomatic Testing
  • Table 6. Key Players of Prenatal Testing
  • Table 7. Global Monogenic Disease Testing Market Size Growth Rate by Application (US$ Million), 2018 VS 2022 VS 2029
  • Table 8. Global Monogenic Disease Testing Market Size Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 9. Global Monogenic Disease Testing Market Size by Region (2018-2023) & (US$ Million)
  • Table 10. Global Monogenic Disease Testing Market Share by Region (2018-2023)
  • Table 11. Global Monogenic Disease Testing Forecasted Market Size by Region (2024-2029) & (US$ Million)
  • Table 12. Global Monogenic Disease Testing Market Share by Region (2024-2029)
  • Table 13. Monogenic Disease Testing Market Trends
  • Table 14. Monogenic Disease Testing Market Drivers
  • Table 15. Monogenic Disease Testing Market Challenges
  • Table 16. Monogenic Disease Testing Market Restraints
  • Table 17. Global Monogenic Disease Testing Revenue by Players (2018-2023) & (US$ Million)
  • Table 18. Global Monogenic Disease Testing Revenue Share by Players (2018-2023)
  • Table 19. Global Top Monogenic Disease Testing by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monogenic Disease Testing as of 2022)
  • Table 20. Global Monogenic Disease Testing Industry Ranking 2021 VS 2022 VS 2023
  • Table 21. Global 5 Largest Players Market Share by Monogenic Disease Testing Revenue (CR5 and HHI) & (2018-2023)
  • Table 22. Global Key Players of Monogenic Disease Testing, Headquarters and Area Served
  • Table 23. Global Key Players of Monogenic Disease Testing, Product and Application
  • Table 24. Global Key Players of Monogenic Disease Testing, Product and Application
  • Table 25. Mergers & Acquisitions, Expansion Plans
  • Table 26. Global Monogenic Disease Testing Market Size by Type (2018-2023) & (US$ Million)
  • Table 27. Global Monogenic Disease Testing Revenue Market Share by Type (2018-2023)
  • Table 28. Global Monogenic Disease Testing Forecasted Market Size by Type (2024-2029) & (US$ Million)
  • Table 29. Global Monogenic Disease Testing Revenue Market Share by Type (2024-2029)
  • Table 30. Global Monogenic Disease Testing Market Size by Application (2018-2023) & (US$ Million)
  • Table 31. Global Monogenic Disease Testing Revenue Share by Application (2018-2023)
  • Table 32. Global Monogenic Disease Testing Forecasted Market Size by Application (2024-2029) & (US$ Million)
  • Table 33. Global Monogenic Disease Testing Revenue Share by Application (2024-2029)
  • Table 34. North America Monogenic Disease Testing Market Size by Type (2018-2023) & (US$ Million)
  • Table 35. North America Monogenic Disease Testing Market Size by Type (2024-2029) & (US$ Million)
  • Table 36. North America Monogenic Disease Testing Market Size by Application (2018-2023) & (US$ Million)
  • Table 37. North America Monogenic Disease Testing Market Size by Application (2024-2029) & (US$ Million)
  • Table 38. North America Monogenic Disease Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 39. North America Monogenic Disease Testing Market Size by Country (2018-2023) & (US$ Million)
  • Table 40. North America Monogenic Disease Testing Market Size by Country (2024-2029) & (US$ Million)
  • Table 41. Europe Monogenic Disease Testing Market Size by Type (2018-2023) & (US$ Million)
  • Table 42. Europe Monogenic Disease Testing Market Size by Type (2024-2029) & (US$ Million)
  • Table 43. Europe Monogenic Disease Testing Market Size by Application (2018-2023) & (US$ Million)
  • Table 44. Europe Monogenic Disease Testing Market Size by Application (2024-2029) & (US$ Million)
  • Table 45. Europe Monogenic Disease Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 46. Europe Monogenic Disease Testing Market Size by Country (2018-2023) & (US$ Million)
  • Table 47. Europe Monogenic Disease Testing Market Size by Country (2024-2029) & (US$ Million)
  • Table 48. China Monogenic Disease Testing Market Size by Type (2018-2023) & (US$ Million)
  • Table 49. China Monogenic Disease Testing Market Size by Type (2024-2029) & (US$ Million)
  • Table 50. China Monogenic Disease Testing Market Size by Application (2018-2023) & (US$ Million)
  • Table 51. China Monogenic Disease Testing Market Size by Application (2024-2029) & (US$ Million)
  • Table 52. Asia Monogenic Disease Testing Market Size by Type (2018-2023) & (US$ Million)
  • Table 53. Asia Monogenic Disease Testing Market Size by Type (2024-2029) & (US$ Million)
  • Table 54. Asia Monogenic Disease Testing Market Size by Application (2018-2023) & (US$ Million)
  • Table 55. Asia Monogenic Disease Testing Market Size by Application (2024-2029) & (US$ Million)
  • Table 56. Asia Monogenic Disease Testing Growth Rate (CAGR) by Region (US$ Million): 2018 VS 2022 VS 2029
  • Table 57. Asia Monogenic Disease Testing Market Size by Region (2018-2023) & (US$ Million)
  • Table 58. Asia Monogenic Disease Testing Market Size by Region (2024-2029) & (US$ Million)
  • Table 59. Middle East, Africa, and Latin America Monogenic Disease Testing Market Size by Type (2018-2023) & (US$ Million)
  • Table 60. Middle East, Africa, and Latin America Monogenic Disease Testing Market Size by Type (2024-2029) & (US$ Million)
  • Table 61. Middle East, Africa, and Latin America Monogenic Disease Testing Market Size by Application (2018-2023) & (US$ Million)
  • Table 62. Middle East, Africa, and Latin America Monogenic Disease Testing Market Size by Application (2024-2029) & (US$ Million)
  • Table 63. Middle East, Africa, and Latin America Monogenic Disease Testing Growth Rate (CAGR) by Country (US$ Million): 2018 VS 2022 VS 2029
  • Table 64. Middle East, Africa, and Latin America Monogenic Disease Testing Market Size by Country (2018-2023) & (US$ Million)
  • Table 65. Middle East, Africa, and Latin America Monogenic Disease Testing Market Size by Country (2024-2029) & (US$ Million)
  • Table 66. Celera Support Services Company Details
  • Table 67. Celera Support Services Business Overview
  • Table 68. Celera Support Services Monogenic Disease Testing Product
  • Table 69. Celera Support Services Revenue in Monogenic Disease Testing Business (2018-2023) & (US$ Million)
  • Table 70. Celera Support Services Recent Developments
  • Table 71. Abbott Company Details
  • Table 72. Abbott Business Overview
  • Table 73. Abbott Monogenic Disease Testing Product
  • Table 74. Abbott Revenue in Monogenic Disease Testing Business (2018-2023) & (US$ Million)
  • Table 75. Abbott Recent Developments
  • Table 76. ELITech Group Company Details
  • Table 77. ELITech Group Business Overview
  • Table 78. ELITech Group Monogenic Disease Testing Product
  • Table 79. ELITech Group Revenue in Monogenic Disease Testing Business (2018-2023) & (US$ Million)
  • Table 80. ELITech Group Recent Developments
  • Table 81. Auto Genomics Company Details
  • Table 82. Auto Genomics Business Overview
  • Table 83. Auto Genomics Monogenic Disease Testing Product
  • Table 84. Auto Genomics Revenue in Monogenic Disease Testing Business (2018-2023) & (US$ Million)
  • Table 85. Auto Genomics Recent Developments
  • Table 86. PerkinElmer Company Details
  • Table 87. PerkinElmer Business Overview
  • Table 88. PerkinElmer Monogenic Disease Testing Product
  • Table 89. PerkinElmer Revenue in Monogenic Disease Testing Business (2018-2023) & (US$ Million)
  • Table 90. PerkinElmer Recent Developments
  • Table 91. Bio-Rad Laboratories Company Details
  • Table 92. Bio-Rad Laboratories Business Overview
  • Table 93. Bio-Rad Laboratories Monogenic Disease Testing Product
  • Table 94. Bio-Rad Laboratories Revenue in Monogenic Disease Testing Business (2018-2023) & (US$ Million)
  • Table 95. Bio-Rad Laboratories Recent Developments
  • Table 96. Research Programs/Design for This Report
  • Table 97. Key Data Information from Secondary Sources
  • Table 98. Key Data Information from Primary Sources

List of Figures

  • Figure 1. Global Monogenic Disease Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 2. Global Monogenic Disease Testing Market Share by Type: 2022 VS 2029
  • Figure 3. Carrier Testing Features
  • Figure 4. Diagnostic Testing Features
  • Figure 5. New-Born Screening Features
  • Figure 6. Predictive and Pre-Symptomatic Testing Features
  • Figure 7. Prenatal Testing Features
  • Figure 8. Global Monogenic Disease Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029 (US$ Million)
  • Figure 9. Global Monogenic Disease Testing Market Share by Application: 2022 VS 2029
  • Figure 10. Hospitals Case Studies
  • Figure 11. Clinics Case Studies
  • Figure 12. Others Case Studies
  • Figure 13. Monogenic Disease Testing Report Years Considered
  • Figure 14. Global Monogenic Disease Testing Market Size (US$ Million), Year-over-Year: 2018-2029
  • Figure 15. Global Monogenic Disease Testing Market Size, (US$ Million), 2018 VS 2022 VS 2029
  • Figure 16. Global Monogenic Disease Testing Market Share by Region: 2022 VS 2029
  • Figure 17. Global Monogenic Disease Testing Market Share by Players in 2022
  • Figure 18. Global Top Monogenic Disease Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Monogenic Disease Testing as of 2022)
  • Figure 19. The Top 10 and 5 Players Market Share by Monogenic Disease Testing Revenue in 2022
  • Figure 20. North America Monogenic Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 21. North America Monogenic Disease Testing Market Share by Type (2018-2029)
  • Figure 22. North America Monogenic Disease Testing Market Share by Application (2018-2029)
  • Figure 23. North America Monogenic Disease Testing Market Share by Country (2018-2029)
  • Figure 24. United States Monogenic Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 25. Canada Monogenic Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 26. Europe Monogenic Disease Testing Market Size YoY (2018-2029) & (US$ Million)
  • Figure 27. Europe Monogenic Disease Testing Market Share by Type (2018-2029)
  • Figure 28. Europe Monogenic Disease Testing Market Share by Application (2018-2029)
  • Figure 29. Europe Monogenic Disease Testing Market Share by Country (2018-2029)
  • Figure 30. Germany Monogenic Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 31. France Monogenic Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 32. U.K. Monogenic Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 33. Italy Monogenic Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 34. Russia Monogenic Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 35. Nordic Countries Monogenic Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 36. China Monogenic Disease Testing Market Size YoY (2018-2029) & (US$ Million)
  • Figure 37. China Monogenic Disease Testing Market Share by Type (2018-2029)
  • Figure 38. China Monogenic Disease Testing Market Share by Application (2018-2029)
  • Figure 39. Asia Monogenic Disease Testing Market Size YoY (2018-2029) & (US$ Million)
  • Figure 40. Asia Monogenic Disease Testing Market Share by Type (2018-2029)
  • Figure 41. Asia Monogenic Disease Testing Market Share by Application (2018-2029)
  • Figure 42. Asia Monogenic Disease Testing Market Share by Region (2018-2029)
  • Figure 43. Japan Monogenic Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 44. South Korea Monogenic Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 45. China Taiwan Monogenic Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 46. Southeast Asia Monogenic Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 47. India Monogenic Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 48. Australia Monogenic Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 49. Middle East, Africa, and Latin America Monogenic Disease Testing Market Size YoY (2018-2029) & (US$ Million)
  • Figure 50. Middle East, Africa, and Latin America Monogenic Disease Testing Market Share by Type (2018-2029)
  • Figure 51. Middle East, Africa, and Latin America Monogenic Disease Testing Market Share by Application (2018-2029)
  • Figure 52. Middle East, Africa, and Latin America Monogenic Disease Testing Market Share by Country (2018-2029)
  • Figure 53. Brazil Monogenic Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 54. Mexico Monogenic Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 55. Turkey Monogenic Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 56. Saudi Arabia Monogenic Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 57. Israel Monogenic Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 58. GCC Countries Monogenic Disease Testing Market Size YoY Growth (2018-2029) & (US$ Million)
  • Figure 59. Celera Support Services Revenue Growth Rate in Monogenic Disease Testing Business (2018-2023)
  • Figure 60. Abbott Revenue Growth Rate in Monogenic Disease Testing Business (2018-2023)
  • Figure 61. ELITech Group Revenue Growth Rate in Monogenic Disease Testing Business (2018-2023)
  • Figure 62. Auto Genomics Revenue Growth Rate in Monogenic Disease Testing Business (2018-2023)
  • Figure 63. PerkinElmer Revenue Growth Rate in Monogenic Disease Testing Business (2018-2023)
  • Figure 64. Bio-Rad Laboratories Revenue Growth Rate in Monogenic Disease Testing Business (2018-2023)
  • Figure 65. Bottom-up and Top-down Approaches for This Report
  • Figure 66. Data Triangulation
  • Figure 67. Key Executives Interviewed
目次

This research report focuses on the Monogenic Disease Testing Market. It analyzes market size, trends and demand forecasts, as well as growth factors and challenges. The report provides market data breakdowns by type, application, company, and region, in addition to competitive landscape and key company profiles.

TABLE OF CONTENTS

1 Report Overview

  • 1.1 Study Scope
  • 1.2 Market Analysis by Type
    • 1.2.1 Global Monogenic Disease Testing Market Size Growth Rate by Type, 2018 VS 2022 VS 2029
    • 1.2.2 Carrier Testing
    • 1.2.3 Diagnostic Testing
    • 1.2.4 New-Born Screening
    • 1.2.5 Predictive and Pre-Symptomatic Testing
    • 1.2.6 Prenatal Testing
  • 1.3 Market by Application
    • 1.3.1 Global Monogenic Disease Testing Market Size Growth Rate by Application, 2018 VS 2022 VS 2029
    • 1.3.2 Hospitals
    • 1.3.3 Clinics
    • 1.3.4 Others
  • 1.4 Assumptions and Limitations
  • 1.5 Study Objectives
  • 1.6 Years Considered

2 Global Growth Trends

  • 2.1 Global Monogenic Disease Testing Market Perspective (2018-2029)
  • 2.2 Global Monogenic Disease Testing Growth Trends by Region
    • 2.2.1 Monogenic Disease Testing Market Size by Region: 2018 VS 2022 VS 2029
    • 2.2.2 Monogenic Disease Testing Historic Market Size by Region (2018-2023)
    • 2.2.3 Monogenic Disease Testing Forecasted Market Size by Region (2024-2029)
  • 2.3 Monogenic Disease Testing Market Dynamics
    • 2.3.1 Monogenic Disease Testing Industry Trends
    • 2.3.2 Monogenic Disease Testing Market Drivers
    • 2.3.3 Monogenic Disease Testing Market Challenges
    • 2.3.4 Monogenic Disease Testing Market Restraints

3 Competition Landscape by Key Players

  • 3.1 Global Revenue Monogenic Disease Testing by Players
    • 3.1.1 Global Monogenic Disease Testing Revenue by Players (2018-2023)
    • 3.1.2 Global Monogenic Disease Testing Revenue Market Share by Players (2018-2023)
  • 3.2 Global Monogenic Disease Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
  • 3.3 Global Key Players of Monogenic Disease Testing, Ranking by Revenue, 2021 VS 2022 VS 2023
  • 3.4 Global Monogenic Disease Testing Market Concentration Ratio
    • 3.4.1 Global Monogenic Disease Testing Market Concentration Ratio (CR5 and HHI)
    • 3.4.2 Global Top 10 and Top 5 Companies by Monogenic Disease Testing Revenue in 2022
  • 3.5 Global Key Players of Monogenic Disease Testing Head office and Area Served
  • 3.6 Global Key Players of Monogenic Disease Testing, Product and Application
  • 3.7 Global Key Players of Monogenic Disease Testing, Date of Enter into This Industry
  • 3.8 Mergers & Acquisitions, Expansion Plans

4 Monogenic Disease Testing Breakdown Data by Type

  • 4.1 Global Monogenic Disease Testing Historic Market Size by Type (2018-2023)
  • 4.2 Global Monogenic Disease Testing Forecasted Market Size by Type (2024-2029)

5 Monogenic Disease Testing Breakdown Data by Application

  • 5.1 Global Monogenic Disease Testing Historic Market Size by Application (2018-2023)
  • 5.2 Global Monogenic Disease Testing Forecasted Market Size by Application (2024-2029)

6 North America

  • 6.1 North America Monogenic Disease Testing Market Size (2018-2029)
  • 6.2 North America Monogenic Disease Testing Market Size by Type
    • 6.2.1 North America Monogenic Disease Testing Market Size by Type (2018-2023)
    • 6.2.2 North America Monogenic Disease Testing Market Size by Type (2024-2029)
    • 6.2.3 North America Monogenic Disease Testing Market Share by Type (2018-2029)
  • 6.3 North America Monogenic Disease Testing Market Size by Application
    • 6.3.1 North America Monogenic Disease Testing Market Size by Application (2018-2023)
    • 6.3.2 North America Monogenic Disease Testing Market Size by Application (2024-2029)
    • 6.3.3 North America Monogenic Disease Testing Market Share by Application (2018-2029)
  • 6.4 North America Monogenic Disease Testing Market Size by Country
    • 6.4.1 North America Monogenic Disease Testing Market Size by Country: 2018 VS 2022 VS 2029
    • 6.4.2 North America Monogenic Disease Testing Market Size by Country (2018-2023)
    • 6.4.3 North America Monogenic Disease Testing Market Size by Country (2024-2029)
    • 6.4.4 United States
    • 6.4.5 Canada

7 Europe

  • 7.1 Europe Monogenic Disease Testing Market Size (2018-2029)
  • 7.2 Europe Monogenic Disease Testing Market Size by Type
    • 7.2.1 Europe Monogenic Disease Testing Market Size by Type (2018-2023)
    • 7.2.2 Europe Monogenic Disease Testing Market Size by Type (2024-2029)
    • 7.2.3 Europe Monogenic Disease Testing Market Share by Type (2018-2029)
  • 7.3 Europe Monogenic Disease Testing Market Size by Application
    • 7.3.1 Europe Monogenic Disease Testing Market Size by Application (2018-2023)
    • 7.3.2 Europe Monogenic Disease Testing Market Size by Application (2024-2029)
    • 7.3.3 Europe Monogenic Disease Testing Market Share by Application (2018-2029)
  • 7.4 Europe Monogenic Disease Testing Market Size by Country
    • 7.4.1 Europe Monogenic Disease Testing Market Size by Country: 2018 VS 2022 VS 2029
    • 7.4.2 Europe Monogenic Disease Testing Market Size by Country (2018-2023)
    • 7.4.3 Europe Monogenic Disease Testing Market Size by Country (2024-2029)
    • 7.4.3 Germany
    • 7.4.4 France
    • 7.4.5 U.K.
    • 7.4.6 Italy
    • 7.4.7 Russia
    • 7.4.8 Nordic Countries

8 China

  • 8.1 China Monogenic Disease Testing Market Size (2018-2029)
  • 8.2 China Monogenic Disease Testing Market Size by Type
    • 8.2.1 China Monogenic Disease Testing Market Size by Type (2018-2023)
    • 8.2.2 China Monogenic Disease Testing Market Size by Type (2024-2029)
    • 8.2.3 China Monogenic Disease Testing Market Share by Type (2018-2029)
  • 8.3 China Monogenic Disease Testing Market Size by Application
    • 8.3.1 China Monogenic Disease Testing Market Size by Application (2018-2023)
    • 8.3.2 China Monogenic Disease Testing Market Size by Application (2024-2029)
    • 8.3.3 China Monogenic Disease Testing Market Share by Application (2018-2029)

9 Asia (excluding China)

  • 9.1 Asia Monogenic Disease Testing Market Size (2018-2029)
  • 9.2 Asia Monogenic Disease Testing Market Size by Type
    • 9.2.1 Asia Monogenic Disease Testing Market Size by Type (2018-2023)
    • 9.2.2 Asia Monogenic Disease Testing Market Size by Type (2024-2029)
    • 9.2.3 Asia Monogenic Disease Testing Market Share by Type (2018-2029)
  • 9.3 Asia Monogenic Disease Testing Market Size by Application
    • 9.3.1 Asia Monogenic Disease Testing Market Size by Application (2018-2023)
    • 9.3.2 Asia Monogenic Disease Testing Market Size by Application (2024-2029)
    • 9.3.3 Asia Monogenic Disease Testing Market Share by Application (2018-2029)
  • 9.4 Asia Monogenic Disease Testing Market Size by Region
    • 9.4.1 Asia Monogenic Disease Testing Market Size by Region: 2018 VS 2022 VS 2029
    • 9.4.2 Asia Monogenic Disease Testing Market Size by Region (2018-2023)
    • 9.4.3 Asia Monogenic Disease Testing Market Size by Region (2024-2029)
    • 9.4.4 Japan
    • 9.4.5 South Korea
    • 9.4.6 China Taiwan
    • 9.4.7 Southeast Asia
    • 9.4.8 India
    • 9.4.9 Australia

10 Middle East, Africa, and Latin America

  • 10.1 Middle East, Africa, and Latin America Monogenic Disease Testing Market Size (2018-2029)
  • 10.2 Middle East, Africa, and Latin America Monogenic Disease Testing Market Size by Type
    • 10.2.1 Middle East, Africa, and Latin America Monogenic Disease Testing Market Size by Type (2018-2023)
    • 10.2.2 Middle East, Africa, and Latin America Monogenic Disease Testing Market Size by Type (2024-2029)
    • 10.2.3 Middle East, Africa, and Latin America Monogenic Disease Testing Market Share by Type (2018-2029)
  • 10.3 Middle East, Africa, and Latin America Monogenic Disease Testing Market Size by Application
    • 10.3.1 Middle East, Africa, and Latin America Monogenic Disease Testing Market Size by Application (2018-2023)
    • 10.3.2 Middle East, Africa, and Latin America Monogenic Disease Testing Market Size by Application (2024-2029)
    • 10.3.3 Middle East, Africa, and Latin America Monogenic Disease Testing Market Share by Application (2018-2029)
  • 10.4 Middle East, Africa, and Latin America Monogenic Disease Testing Market Size by Country
    • 10.4.1 Middle East, Africa, and Latin America Monogenic Disease Testing Market Size by Country: 2018 VS 2022 VS 2029
    • 10.4.2 Middle East, Africa, and Latin America Monogenic Disease Testing Market Size by Country (2018-2023)
    • 10.4.3 Middle East, Africa, and Latin America Monogenic Disease Testing Market Size by Country (2024-2029)
    • 10.4.4 Brazil
    • 10.4.5 Mexico
    • 10.4.6 Turkey
    • 10.4.7 Saudi Arabia
    • 10.4.8 Israel
    • 10.4.9 GCC Countries

11 Key Players Profiles

  • 11.1 Celera Support Services
    • 11.1.1 Celera Support Services Company Details
    • 11.1.2 Celera Support Services Business Overview
    • 11.1.3 Celera Support Services Monogenic Disease Testing Introduction
    • 11.1.4 Celera Support Services Revenue in Monogenic Disease Testing Business (2018-2023)
    • 11.1.5 Celera Support Services Recent Developments
  • 11.2 Abbott
    • 11.2.1 Abbott Company Details
    • 11.2.2 Abbott Business Overview
    • 11.2.3 Abbott Monogenic Disease Testing Introduction
    • 11.2.4 Abbott Revenue in Monogenic Disease Testing Business (2018-2023)
    • 11.2.5 Abbott Recent Developments
  • 11.3 ELITech Group
    • 11.3.1 ELITech Group Company Details
    • 11.3.2 ELITech Group Business Overview
    • 11.3.3 ELITech Group Monogenic Disease Testing Introduction
    • 11.3.4 ELITech Group Revenue in Monogenic Disease Testing Business (2018-2023)
    • 11.3.5 ELITech Group Recent Developments
  • 11.4 Auto Genomics
    • 11.4.1 Auto Genomics Company Details
    • 11.4.2 Auto Genomics Business Overview
    • 11.4.3 Auto Genomics Monogenic Disease Testing Introduction
    • 11.4.4 Auto Genomics Revenue in Monogenic Disease Testing Business (2018-2023)
    • 11.4.5 Auto Genomics Recent Developments
  • 11.5 PerkinElmer
    • 11.5.1 PerkinElmer Company Details
    • 11.5.2 PerkinElmer Business Overview
    • 11.5.3 PerkinElmer Monogenic Disease Testing Introduction
    • 11.5.4 PerkinElmer Revenue in Monogenic Disease Testing Business (2018-2023)
    • 11.5.5 PerkinElmer Recent Developments
  • 11.6 Bio-Rad Laboratories
    • 11.6.1 Bio-Rad Laboratories Company Details
    • 11.6.2 Bio-Rad Laboratories Business Overview
    • 11.6.3 Bio-Rad Laboratories Monogenic Disease Testing Introduction
    • 11.6.4 Bio-Rad Laboratories Revenue in Monogenic Disease Testing Business (2018-2023)
    • 11.6.5 Bio-Rad Laboratories Recent Developments

12 Analyst's Viewpoints/Conclusions

13 Appendix

  • 13.1 Research Methodology
    • 13.1.1 Methodology/Research Approach
    • 13.1.2 Data Source
  • 13.2 Disclaimer
  • 13.3 Author Details